JIR
OSCR icon

James Investment Research’s Oscar Health OSCR Stock Holding History

James Investment Research’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,354
Closed -$243K – 359
2025
Q2 		$243K Sell
11,354
-3,772
-25% -$56.1K 0.03% 289
2025
Q1 		$198K Buy
+15,126
New +$225K 0.03% 299

Other funds holding OSCR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

James Investment Research's OSCR Position: Q3 2025 in Review

James Investment Research sold out of Oscar Health (OSCR) in Q3 2025, closing a stake of 11,354 shares — an estimated $243K sold.

James Investment Research first reported a position in OSCR in Q1 2025 and held it in 2 quarters. The position peaked at $243K in Q2 2025. 343 funds tracked by Wall St. Rank hold OSCR as of Q3 2025.

  • James Investment Research reported no remaining Oscar Health position as of Q3 2025 after selling out during the quarter.
  • James Investment Research sold 11,354 Oscar Health shares in Q3 2025, an estimated $243K.
  • James Investment Research first reported a position in Oscar Health in Q1 2025 and held it in 2 quarters.
  • James Investment Research's Oscar Health position peaked at $243K in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Oscar Health as of Q3 2025.

Based on James Investment Research's 13F filing for Q3 2025, filed 31 Oct 2025.